Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
QuestionPro Acquires SpatialChat - a Leading European Video Streaming & Collaboration Platform
-
Provident Bank Announces $50,000 in Grants to 11 Small Businesses and 4 Non-Profit Organizations
-
AgEagle Aerial Systems Completes Order for eBee VISION Drones from Danish Ministry of Defence Acquisition and Logistics Organisation (DALO)
-
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
-
Genius Group increases Bitcoin Treasury to total purchase of 214 Bitcoin for $20 million
-
Aemetis Registrations Approved by the IRS for 45Z Production Tax Credits
-
SaverOne Continues to Expand its Global Reach with New Distribution Agreement with Smartfits in the UK
-
Giftify’s CardCash Partners with Susan G. Komen to Transform Unused Gift Cards into Donations for Breast Cancer Research
-
Responding to That Last Minute Gift Emergency
-
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025
-
Kratos Awarded $6.5 Million Contract to Provide Flight Testing for Hypersonic Research to Support Future Weapon Systems from DARPA
-
BBSI Establishes Vice Chairman Role, Appoints Current Board Member Joseph Clabby
-
Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761
-
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
-
HERE Technologies brings AI-powered mapping and software-defined vehicle innovations to CES 2025 after milestone year
-
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Despite Organizations Scrambling to Adapt Following the 2024 Election, Nearly 90% of SMB Owners Surveyed Remain Optimistic for 2025
-
Avalyn to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Walrus Pump Announces Financial and Operating Results for Three Quarters of FY2024
-
WEBs Investments Inc. and Westwood Holdings Group Launch Defined Volatility℠ ETF Series with Debut of DVSP and DVQQ
-
Net Asset Value(s)
-
RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine
-
Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity
-
Copenhagen Infrastructure Partners acquires majority stake in ABO Energy’s wind and hydrogen project
-
USA Rare Earth Appoints Joshua Ballard as Chief Executive Officer
-
OFFER UPDATE – USE OF OVER-ALLOTMENT FACILITY
-
Wearable Devices and RayNeo Unveil First Neural-Controlled AR Glasses at CES 2025, Serving as the Catalyst for Strategic Collaborations and OEM Integrations
-
Demesne Resources Ltd. Confirms Underground Access to Tungsten Vein System, IMA Mine Project in Idaho, USA
-
Cartier Cuts 44.7 g/t Au over 0.5 m and 7.5 g/t Au over 4.6 m Extending to 10 km the High-Grade Gold Potential at East Cadillac
-
Prime Drink Group Announces Private Placement
-
VR Resources Completes Phase 1 Drilling at Empire Project in Ontario
-
Encouraging Initial Drilling Results Reported from the Pense Critical Metals Project
-
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium
-
AppTech Announces $5,000,000 Common Equity Raise and Board Member Changes
-
ZenaTech to Use Quantum Computing for Wildfire Tracking in the Western US; Part of a Third LOI for Land Survey Company Acquisition
-
Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
-
Prairie Operating Co. To Host Year-End Update Call Highlighting Current Operations and Key Achievements in 2024
-
Red Pine Prospecting Program Discovers Additional Gold Mineralization Immediately West of the Existing Mineral Resource and Acquires Strategic Mining Claim
-
Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease
-
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
-
REE Automotive Reports Q3 2024 Results: Reservations Surge by 230% as Production Begins and Liquidity Increases, Reaffirming BoM Breakeven Target for H2 2025
-
MINILUXE ANNOUNCES FRANCHISEE OPERATOR PARTNERSHIP
-
Form 8.3 - [LOUNGERS PLC - 16 12 2024] - (CGWL)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 16 12 2024] - (CGWL)
-
Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence
-
Wellpath Partners with Awell to Improve Quality of Care through Data-Driven Improvements
-
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
-
BexBack Launches Double Deposit Bonus, $50 Welcome Bonus and 100x Leverage Crypto Trading No KYC
-
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
